PAREXEL Renames Perceptive Informatics Subsidiary
PAREXEL announced a group of initiatives that include a re-designed corporate website
PAREXEL announced a group of initiatives that include a re-designed corporate website, a global marketing and advertising campaign and the rebranding of its technology subsidiary Perceptive Informatics to PAREXEL informatics.
According to the company's press release, the PAREXEL Informatics branding is in response to sponsors seeking multiple solutions from a single service provider. Said Mark A. Goldberg, President and Chief Operating Officer, PAREXEL in that release, "We are more closely integrating our clinical research and technology offerings to meet this need. Toward that end, the new PAREXEL Informatics branding communicates our commitment to providing technology-driven solutions that complement our other clinical trial services, without changing our overall go-to-market strategy."
PAREXEL will maintain the Perceptive brands to identify specific PAREXEL Informatics offerings that have market recognition that has been built over the years. These include Perceptive MyTrials eClinical platform, the Perceptive Partner Program and the Perceptive Institute.
Read the full release here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Study Finds Many Randomized Clinical Trials Have Poorly Justified Exclusion Criteria
January 21st 2025Investigators find that most exclusion criteria in critical care randomized clinical trials are justifiable, but 60% include at least one poorly justified exclusion, most commonly affecting pregnant or lactating individuals.
